Technology | Computed Tomography (CT) | February 15, 2017

GE Healthcare Announces FDA Clearance of GSI Xtream on Revolution CT

GSI Xtream brings volume spectral CT technology to Revolution CT

GE Healthcare, GSI Xtream, FDA clearance, spectral CT, Revolution, RSNA 2017

February 15, 2017 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of GSI Xtream on Revolution CT (computed tomography). The company also announced the first series of clinical images and first installations at Duke University Medical Center (USA), Robarts Research Institute (Canada) and The First Affiliated Hospital of Dalian Medical University (China).

GSI Xtream on Revolution CT is the first volume spectral CT technology designed to improve small lesion detection, tissue characterization and metal artifact reduction, with a simplified workflow.

From setup to post processing, GE said GSI Xtream is as intuitive as a single energy exam. GSI Assist and Clinical ID help standardize and automate protocol selection with images directly transferred to picture archiving and communication systems (PACS) and/or automated workflow (AW). These improvements, combined with native GSI reconstruction, deliver spectral CT workflow that is twice as fast compared to the Revolution HD.

Spectral CT allows clinicians to go beyond anatomy visualization to tissue characterization, allowing for differentiation between similar HU densities such as cysts and enhancing lesions. With a contrast-to-noise ratio 60 percent higher at 120 kV than single energy CT, monochromatic images improve lesion detection and enhance contrast. Bhavik Patel, M.D., assistant professor of radiology, Duke Medical Center, said “By using GSI, we may be able to characterize a lesion for diagnosis from one exam, which could generate cost savings and add value – both clinically for the patient and economically for the health system.”

GSI Xtream enhances Revolution CT’s platform with wide collimation and 50 cm field-of-view (FOV) to deliver the only volume spectral CT. Enabled by ultrafast kV switching, clinicians can scan more challenging patients and reduce the effects of motion. The Gemstone Clarity detector combined with ASiR-V delivers dose neutral exams for patients of any size.

For more information: www.gehealthcare.com

Related Content

Accuray Incorporated announced the company has received CE Mark certification for its ClearRT helical fan-beam kVCT imaging capability.
News | Radiation Therapy | June 11, 2021
June 11, 2021 — Accuray Incorporated announced the company has received CE Mark certification for its...
News | PET-CT | June 10, 2021
June 10, 2021 — Bringing the power of...
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
An example of how spectral CT can help aid diagnosis in a pancreatic CT which may have a small lesion, but it is difficult to see. The dual-energy imaging clearly shows a lesion. This is example is from the Philips Spectral CT 7500 system.

An example of how spectral CT can help aid diagnosis in a pancreatic CT which may have a small lesion, but it is difficult to see. The dual-energy imaging clearly shows a lesion. This is example is from the Philips Spectral CT 7500 system.

Feature | Computed Tomography (CT) | May 27, 2021 | By Dave Fornell, Editor
May 27, 2021 — Philips Healthcare released a workhorse...
(A) 70-year-old woman with pulmonary adenocarcinoma who underwent sublobar resection without evidence for pLVI. 15-mm solid nodule with irregular margins present in right lower lobe (arrow). No tumor recurrence on 37-month follow-up. (B) 75-year-old man with pulmonary adenocarcinoma who underwent wedge resection that exhibited pLVI. 19-mm solid nodule with irregular margins and peritumoral interstitial thickening (arrowheads) present in right upper lobe. Ipsilateral mediastinal and hilar lymph node metastas

(A) 70-year-old woman with pulmonary adenocarcinoma who underwent sublobar resection without evidence for pLVI. 15-mm solid nodule with irregular margins present in right lower lobe (arrow). No tumor recurrence on 37-month follow-up. (B) 75-year-old man with pulmonary adenocarcinoma who underwent wedge resection that exhibited pLVI. 19-mm solid nodule with irregular margins and peritumoral interstitial thickening (arrowheads) present in right upper lobe. Ipsilateral mediastinal and hilar lymph node metastasis occurred after 5-month follow-up (not shown). Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | May 18, 2021
May 18, 2021 — According to an open-access Editor's Choice article in ARRS' ...
According to the CDC, if you are fully vaccinated you can start doing many things that you had stopped doing because of the pandemic. Infographic courtesy of the CDC.

According to the CDC, if you are fully vaccinated you can start doing many things that you had stopped doing because of the pandemic. Infographic courtesy of the CDC.

News | Coronavirus (COVID-19) | May 13, 2021
May 13, 2021 — The Centers for Disease Control and Prevention (CDC) just